the Company’s existing at-the-market offering pursuant to its sales agreement with Roth Capital Partners, LLC and Bancroft Capital LLC dated November 26, 2025 will not be deemed a Variable Rate Transaction
the Company’s existing at-the-market offering pursuant to its sales agreement with Roth Capital Partners, LLC and Bancroft Capital LLC dated November 26, 2025 will not be deemed a Variable Rate Transaction
Reciprocal relationship from COST graph: Reciprocal relationship from SNYR graph: 017, between Knight Therapeutics Inc. and Sneaky Vaunt Corp. (incorporated by reference to Exhibit 10.26 to the Regis…
017, between Knight Therapeutics Inc. and Sneaky Vaunt Corp. (incorporated by reference to Exhibit 10.26 to the Registration Statement on Form S-1, filed by Synergy CHC Corp. on June 28, 2024). 10.27…
As of March 31, 2026 and December 31, 2025, three customers and one customer accounted for 58 % and 71 %, respectively, of the Company’s trade accounts receivable.
Synergy CHC Corp. Debt Obligations
Instrument
Description
Confidence
Evidence
SNYR-DEBT-12657
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
SNYR-DEBT
Debt stack $27.7M
90%
Market cache reports total debt of $27.7M.
SNYR-DEBT-12656
Warrants outstanding: 103500
90%
xbrl warrant detail from xbrl 2025-12-31.
Synergy CHC Corp. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Synergy CHC Corp..
Synergy CHC Corp. Ownership
Holder
Name
Confidence
Evidence
SNYR-OWNER-GRATIA-CAPITAL-LLC
GRATIA CAPITAL, LLC
90%
13F overlay lists GRATIA CAPITAL, LLC as top holder; 13 tracked holders.